Svensjo E, Boschcov P, Ketelhuth DFJ, Jancar S, Gidlund M: Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins. Lowry OH, Rosebbough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. Uint L, Gebara OCE, Pinto LB, Boschcov P, Luz PL, Gildund M: Hormone replacement therapy (HRT) increases antibodies against heat shock protein 65 (Hsp 65) and oxidized LDL (oxLDL). Autoimmunity Rev 1:21-27, 2002ĭamasceno NR, Goto H, Rodrigues FM, Dias CT, Okawabata FS, Abdalla DS, Gidlund M: Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. Sherer Y, Shoenfeld Y: Immunomodulation for treatment and prevention of atherosclerosis. Van de Vijver LP, Steyger R, van Poppel G, Boer JM, Kruijssen DA, Seidell JC, Princen HM: Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
Hulthe J, Wikstrand J, Lidell A, Wendelhag I, Hansson GK, Wiklund O: Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia.
Uusitupa MI, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Yla-Herttuala S: Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, Emoto M, Kawagishi T, Morii H: Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Zaratin A, Gidlund M, Boschcov P, Castilho L, Cotta de Faria E: Antibodies against oxidized low-density lipoprotein in normolipidemic smokers. J Hypertens 13:129-138, 1995īergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J: Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G: Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: A biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T: Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arteriosclerosis 10:325-335, 1990īui MN, Sack MN, Moutsatsos G, Lu DY, Katz P, McCown R, Breall JA, Rackley CE: Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Shoenfeld Y, Sherer Y, George J, Harats D: Autoantibodies associated with atherosclerosis. Zhou X, Hansson GK: Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Ross R: The patogenesis of atherosclerosis: A perspective for the 1990s. Jonasson L, Holm J, Skalli O, Bondjers G, and Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. J Intern Med 247:349-358, 2000įolcik VA, Aamir R, Cathcart MK: Cytokine modulation of LDL oxidation by activated human monocytes. Libby P: Changing concepts of atherogenesis.
#Lego han solo carbonite review free
Free Radic Biol Med 13:341-390, 1992įrostegard J, Haegerstrand A, Gidlund M, Nilsson J: Biologically modified LDL increases the adhesive properties of endothelial cells. N Engl J Med 320:915-924, 1989Įsterbauer H, Gebicki J, Puhl H, Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Modifications of low-density lipoprotein that increase its atherogenicity. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Ross R: Atherosclerosis-An inflammatory disease. Ross R, Glomset JA: The pathogenesis of atherosclerosis.
0 kommentar(er)
